person

Hilary O.

Country
Ireland
Department
Haematology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 69 partner sites.

Specializations

Hematologic Malignancies

Hilary O'Leary leads investigations into blood‑borne cancers, emphasizing Acute Myeloid Leukemia and its myelodysplastic precursors.

  • Chronic lymphocytic leukemia
  • Multiple Myeloma
  • Diffuse Large B‑Cell Lymphoma
  • Waldenström’s macroglobulinemia
  • Myelodysplastic syndromes

Research aims to improve survival and disease‑free intervals for patients across these entities.

Solid Tumor Oncology

The investigator focuses on major solid cancers, including prostate cancer and advanced ovarian epithelial cancer.

  • Colorectal cancer
  • Stomach cancer
  • Esophageal cancer
  • Pancreatic cancer
  • Fallopian tube cancer

Efforts target novel therapeutic combinations to extend progression‑free survival.

Lung Cancer

Hilary O'Leary contributes to studies of Non‑Small Cell Lung Cancer, with special attention to KRAS‑mutated subtypes.

  • Advanced NSCLC
  • KRAS‑G12C mutant NSCLC
  • Stage IV NSCLC
  • Metastatic NSCLC
  • Early stage NSCLC

Clinical work seeks to optimize targeted and immunotherapeutic regimens.

Breast Cancer

Her portfolio includes diverse breast‑cancer subtypes, from hormone‑responsive to triple‑negative disease.

  • HR‑positive/HER2‑negative early breast cancer
  • HER2‑positive breast cancer
  • Triple‑negative breast cancer
  • High‑risk HER2‑positive breast cancer
  • Premenopausal HR‑positive/HER2‑negative breast cancer

The aim is to refine adjuvant strategies and reduce recurrence.

Infectious and Thrombotic Conditions

Beyond oncology, the investigator addresses acute infections and clotting disorders, such as COVID‑19 and venous thromboembolism.

  • Cystic Fibrosis
  • SARS‑CoV‑2 infection
  • Venous thromboembolism
  • Stroke
  • Surgical site infection

Studies aim to define effective prophylaxis and treatment pathways.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.